Thomas Krieg

Title: Thomas Krieg: Innovator in Succinate Dehydrogenase Inhibitors

Introduction

Thomas Krieg is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of succinate dehydrogenase inhibitors. His work focuses on innovative solutions for treating reperfusion injuries, which can occur during ischemia-reperfusion events.

Latest Patents

Thomas Krieg holds 1 patent for his invention related to succinate dehydrogenase inhibitors (SDHi's). This invention pertains to a succinate dehydrogenase inhibitor or a prodrug and/or a pharmaceutically acceptable salt thereof. It is designed for use in the treatment or prevention of reperfusion injury by inhibiting the accumulation of succinate. The inhibitor or prodrug is characterized as a cell-permeable reversible inhibitor of succinate dehydrogenase.

Career Highlights

Throughout his career, Thomas Krieg has worked with various organizations, including United Kingdom Research and Innovation. His expertise in the field has allowed him to contribute to advancements in medical treatments and therapies.

Collaborations

Thomas has collaborated with notable individuals such as Lorraine Work and Michael Patrick Murphy. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Thomas Krieg is a distinguished inventor whose work on succinate dehydrogenase inhibitors has the potential to significantly impact the treatment of reperfusion injuries. His contributions to the field exemplify the importance of innovation in medical science.